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The Amino Terminus of Herpes Simplex Virus Type 1 Glycoprotein K
(gK) Modulates gB-Mediated Virus-Induced Cell Fusion and
Virion Egress䌤
Vladimir N. Chouljenko, Arun V. Iyer, Sona Chowdhury,
Dmitry V. Chouljenko, and Konstantin G. Kousoulas*
Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of
Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana 70803

Herpes simplex virus type 1 (HSV-1)-induced cell fusion is mediated by viral glycoproteins and other
membrane proteins expressed on infected cell surfaces. Certain mutations in the carboxyl terminus of HSV-1
glycoprotein B (gB) and in the amino terminus of gK cause extensive virus-induced cell fusion. Although gB
is known to be a fusogenic glycoprotein, the mechanism by which gK is involved in virus-induced cell fusion
remains elusive. To delineate the amino-terminal domains of gK involved in virus-induced cell fusion, the
recombinant viruses gK⌬31-47, gK⌬31-68, and gK⌬31-117, expressing gK carrying in-frame deletions spanning the amino terminus of gK immediately after the gK signal sequence (amino acids [aa] 1 to 30), were
constructed. Mutant viruses gK⌬31-47 and gK⌬31-117 exhibited a gK-null (⌬gK) phenotype characterized by
the formation of very small viral plaques and up to a 2-log reduction in the production of infectious virus in
comparison to that for the parental HSV-1(F) wild-type virus. The gK⌬31-68 mutant virus formed substantially larger plaques and produced 1-log-higher titers than the gK⌬31-47 and gK⌬31-117 mutant virions at low
multiplicities of infection. Deletion of 28 aa from the carboxyl terminus of gB (gB⌬28syn) caused extensive
virus-induced cell fusion. However, the gB⌬28syn mutation was unable to cause virus-induced cell fusion in the
presence of the gK⌬31-68 mutation. Transient expression of a peptide composed of the amino-terminal 82 aa
of gK (gKa) produced a glycosylated peptide that was efficiently expressed on cell surfaces only after infection
with the HSV-1(F), gK⌬31-68, ⌬gK, or UL20-null virus. The gKa peptide complemented the gK⌬31-47 and
gK⌬31-68 mutant viruses for infectious-virus production and for gK⌬31-68/gB⌬28syn-mediated cell fusion.
These data show that the amino terminus of gK modulates gB-mediated virus-induced cell fusion and virion
egress.

Herpes simplex virus type 1 (HSV-1) specifies at least 11
virally encoded glycoproteins, as well as several nonglycosylated and lipid-anchored membrane-associated proteins, which
serve important functions in virion infectivity and virus spread.
Although cell-free enveloped virions can efficiently spread viral
infection, virions can also spread by causing cell fusion of
adjacent cellular membranes. Virus-induced cell fusion, which
is caused by viral glycoproteins expressed on infected cell surfaces, enables transmission of virions from one cell to another,
avoiding extracellular spaces and exposure of free virions to
neutralizing antibodies (reviewed in reference 56). Most mutations that cause extensive virus-induced cell-to-cell fusion
(syncytial or syn mutations) have been mapped to at least four
regions of the viral genome: the UL20 gene (5, 42, 44); the
UL24 gene (37, 58); the UL27 gene, encoding glycoprotein B
(gB) (9, 51); and the UL53 gene, coding for gK (7, 15, 35, 53,
54, 57).
Increasing evidence suggests that virus-induced cell fusion is
mediated by the concerted action of glycoproteins gD, gB, and
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gH/gL. Recent studies have shown that gD interacts with
both gB and gH/gL (1, 2). Binding of gD to its cognate
receptors, including Nectin-1, HVEM, and others (12, 29,
48, 59, 60, 62, 63), is thought to trigger conformation
changes in gH/gL and gB that cause fusion of the viral
envelope with cellular membranes during virus entry and
virus-induced cell fusion (32, 34). Transient coexpression of
gB, gD, and gH/gL causes cell-to-cell fusion (49, 68). However, this phenomenon does not accurately model viral fusion, because other viral glycoproteins and membrane proteins known to be important for virus-induced cell fusion are
not required (6, 14, 31). Specifically, gK and UL20 were
shown to be absolutely required for virus-induced cell fusion
(21, 46). Moreover, syncytial mutations within gK (7, 15, 35,
53, 54, 57) or UL20 (5, 42, 44) promote extensive virusinduced cell fusion, and viruses lacking gK enter more
slowly than wild-type virus into susceptible cells (25). Furthermore, transient coexpression of gK carrying a syncytial
mutation with gB, gD, and gH/gL did not enhance cell
fusion, while coexpression of the wild-type gK with gB, gD,
and gH/gL inhibited cell fusion (3).
Glycoproteins gB and gH are highly conserved across all
subfamilies of herpesviruses. gB forms a homotrimeric type I
integral membrane protein, which is N glycosylated at multiple
sites within the polypeptide. An unusual feature of gB is that
syncytial mutations that enhance virus-induced cell fusion are
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located exclusively in the carboxyl terminus of gB, which is
predicted to be located intracellularly (51). Single-amino-acid
substitutions within two regions of the intracellular cytoplasmic
domain of gB were shown to cause syncytium formation and
were designated region I (amino acid [aa] positions 816 and
817) and region II (aa positions 853, 854, and 857) (9, 10, 28,
69). Furthermore, deletion of 28 aa from the carboxyl terminus
of gB, disrupting the small predicted alpha-helical domain
H17b, causes extensive virus-induced cell fusion as well as
extensive glycoprotein-mediated cell fusion in the gB, gD, and
gH/gL transient-coexpression system (22, 49, 68). The X-ray
structure of the ectodomain of gB has been determined and is
predicted to assume at least two major conformations, one of
which may be necessary for the fusogenic properties of gB.
Therefore, perturbation of the carboxyl terminus of gB may
alter the conformation of the amino terminus of gB, thus
favoring one of the two predicted conformational structures
that causes membrane fusion (34).
The UL53 (gK) and UL20 genes encode multipass transmembrane proteins of 338 and 222 aa, respectively, which are
conserved in all alphaherpesviruses (15, 42, 55). Both proteins
have multiple sites where posttranslational modification can
occur; however, only gK is posttranslationally modified by Nlinked carbohydrate addition (15, 35, 55). The specific membrane topologies of both gK and UL20 protein (UL20p) have
been predicted and experimentally confirmed using epitope
tags inserted within predicted intracellular and extracellular
domains (18, 21, 44). Syncytial mutations in gK map predominantly within extracellular domains of gK and particularly
within the amino-terminal portion of gK (domain I) (18), while
syncytial mutations of UL20 are located within the amino terminus of UL20p, shown to be located intracellularly (44). A
series of recent studies have shown that HSV-1 gK and UL20
functionally and physically interact and that these interactions
are necessary for their coordinate intracellular transport and
cell surface expression (16, 18, 21, 26, 45). Specifically, direct
protein-protein interactions between the amino terminus of
HSV-1 UL20 and gK domain III, both of which are localized
intracellularly, were recently demonstrated by two-way coimmunoprecipitation experiments (19).
According to the most prevalent model for herpesvirus
intracellular morphogenesis, capsids initially assemble
within the nuclei and acquire a primary envelope by budding
into the perinuclear spaces. Subsequently, these virions lose
their envelope through fusion with the outer nuclear lamellae. Within the cytoplasm, tegument proteins associate with
the viral nucleocapsid and final envelopment occurs by budding of cytoplasmic capsids into specific trans-Golgi network
(TGN)-associated membranes (8, 30, 47, 70). Mature virions
traffic to cell surfaces, presumably following the cellular
secretory pathway (33, 47, 61). In addition to their significant roles in virus-induced cell fusion, gK and UL20 are
required for cytoplasmic virion envelopment. Viruses with
deletions in either the gK or the UL20 gene are unable to
translocate from the cytoplasm to extracellular spaces and
accumulated as unenveloped virions in the cytoplasm (5, 15,
20, 21, 26, 35, 36, 38, 44, 55). Current evidence suggests that
the functions of gK and UL20 in cytoplasmic virion envelopment and virus-induced cell fusion are carried out by
different, genetically separable domains of UL20p. Specifi-
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cally, UL20 mutations within the amino and carboxyl termini of UL20p allowed cotransport of gK and UL20p to cell
surfaces, virus-induced cell fusion, and TGN localization,
while effectively inhibiting cytoplasmic virion envelopment
(44, 45).
In this paper, we demonstrate that the amino terminus of gK
expressed as a free peptide of 82 aa (gKa) is transported to
infected cell surfaces by viral proteins other than gK or UL20p
and facilitates virus-induced cell fusion caused by syncytial
mutations in the carboxyl terminus of gB. Thus, functional
domains of gK can be genetically separated, as we have shown
previously (44, 45), as well as physically separated into different
peptide portions that retain functional activities of gK. These
results are consistent with the hypothesis that the amino terminus of gK directly or indirectly interacts with and modulates
the fusogenic properties of gB.

MATERIALS AND METHODS
Cells. African green monkey kidney (Vero) cells and human embryonic kidney
(HEK293T) cells were obtained from the American Type Culture Collection
(Rockville, MD). Cells were maintained in Dulbecco’s modified Eagle’s medium
(Gibco-BRL, Grand Island, NY) supplemented with 10% fetal calf serum and
antibiotics. The gK-transformed cell line VK302 was originally obtained from
D. C. Johnson, Oregon Health Sciences University, and maintained as described
earlier (20, 36).
Plasmids. A gene cassette encoding the gKa peptide was constructed to include a 3⫻ FLAG epitope inserted in frame after gK aa 82 and cloned into
transient expression vector p3XFLAG-CMV14 (Invitrogen, Inc.). gKa-A40V
and gKa-A40T plasmids were constructed by PCR-assisted mutagenesis using
the gKa plasmid as the template, as described previously (13). The gKa-R
plasmid contained the same 82-aa sequence cloned in reverse orientation into
the pcDNA 3.1 plasmid (Invitrogen). Plasmids expressing T7 polymerase, the
firefly luciferase gene under T7 promoter control, and plasmid control vector
pCAGGS were obtained from Richard Longnecker (Northwestern University).
Recombinant-virus construction. The mutant viruses gK⌬31-47 (encoding gK
carrying an in-frame deletion of aa 31 to 47), gK⌬31-68, gK⌬31-117, gK-null
(⌬gK), gB⌬28syn (deletion of 28 aa from the carboxyl terminus of gB), and
gK⌬31-68/gB⌬28syn were created as described earlier (40), using a markerless
two-step red recombination mutagenesis system (67) implemented on the bacterial artificial chromosome plasmid pYEbac102 carrying the HSV-1(F) genome
(a kind gift from Y. Kawaguchi, Japan). All ⌬gK recombinant viruses specified
gK carrying in-frame deletions spanning the amino terminus of gK immediately
after the gK signal sequence (aa 1 to 30). The ⌬gK recombinant virus was created
by inserting a kanamycin resistance cassette after aa position 17 within the gK
signal sequence. The recombinant virus gB⌬28syn was constructed by deleting
the carboxyl-terminal 28 aa of gB and inserting one stop codon at the site of the
deletion. This viral genome was utilized for construction of the double mutant
virus gK⌬31-68/gB⌬28syn.
Plaque morphology and one-step viral growth kinetics. Visual analysis of
plaque morphology of mutant viruses was performed essentially as we have
described previously (27, 44, 46). Specifically, photographs of viral plaques were
taken at a ⫻25 magnification on a Leica model DM IRB inverted wide-angle
microscope. Seventy randomly selected plaques were imaged for each virus.
The resulting images were analyzed using Zeiss AxioVision SP1 software, release
4.7.1.0 (Carl Zeiss MicroImaging GmbH, Jena, Germany), to determine the area
of each plaque in square pixels. The plaque area measurements were analyzed
using the SAS statistical package, version 9.1.3. Distributions were examined for
normality using the univariate procedure with a Shapiro-Wilks test of normality.
The general linear-model procedure was used to conduct a one-way analysis of
variance on the data. When overall analyses determined significance (P ⱕ 0.05),
Tukey’s honestly significant difference test was used to examine pairwise differences between the means for each of the five mutants.
One-step growth kinetics was performed as we have described previously (18,
21, 25). Briefly, viruses were adsorbed on wells of a six-well plate of nearly
confluent Vero cell monolayers at 4°C for 1 h at a multiplicity of infection (MOI)
of 0.1 (low MOI) and an MOI of 2 (high MOI). Thereafter, plates were incubated at 37°C and 5% CO2 and virus was allowed to penetrate for 1 h at 37°C.
Any remaining extracellular virus was inactivated by low-pH treatment (pH 3.0),
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and cells were incubated at 37°C and 5% CO2. Supernatants and cell pellets (in
the same volume of cell medium as supernatants) were collected at different
times postinfection and stored at ⫺80°C. Virus titers were determined (in triplicate) by endpoint titration of virus stocks on VK302 cells.
Transfections and Western immunoblot analyses. Subconfluent Vero cells in
six-well plates were transfected with 5 g of plasmid gKa using Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s directions. Twentyfour hours posttransfection, cells were infected with the gB⌬28syn virus (MOI of
2). Twenty-four hours postinfection (hpi), cells were processed for Western blot
analysis. Cells were collected by low-speed centrifugation, washed with phosphate-buffered saline (PBS), and lysed at room temperature for 15 min in
mammalian protein extraction reagent supplemented with a cocktail of protease
inhibitors (Invitrogen-Life Technologies, Carlsbad, CA). Lysed Vero cell extracts
were treated with endoglycosidase H (endo H) or peptide N-glycosidase F
(PNGase F) as recommended by manufacturer instructions. Samples were further processed for sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and immunoblotting as detailed previously (19, 25, 40).
Complementation of the replication of gK mutant viruses by the gKa peptide.
Nearly confluent monolayers of Vero cells (triplicates) were transfected with
either gKa or control gKa-R plasmid containing the gKa coding sequence
cloned in the reverse orientation. Twenty-four hours posttransfection, cells
were infected with either the gK⌬31-47 or the gK⌬31-68 virus. Virus stocks
were prepared at 9 and 21 hpi, and virus titers were determined on VK302
cell monolayers as described above.
Immunohistochemistry/immunocytochemistry. Vero cell monolayers in 12well plates were transfected with gKa and gKa-R. Twenty-four hours posttransfection, cells were infected at an MOI of 0.2 with gK⌬31-68/gB⌬28syn. Thirty
hpi, monolayers were washed with Tris-buffered saline (TBS)–Ca-Mg and either
fixed with 100% methanol for 10 min or left unfixed (live). Immunohistochemistry was performed by utilizing a Vector Laboratories Vectastain Elite ABC kit
essentially as described in the manufacturer’s directions. Briefly, cells were
washed with TBS–Ca-Mg and incubated in TBS blocking buffer supplemented
with normal horse serum-normal goat serum at room temperature for 1 h. After
the blocking step, cells were incubated with anti-FLAG antibody (1:500) (Sigma
Chemical) or polyclonal rabbit anti-HSV-1 antibody (1:500) (Dako) in TBS
blocking buffer for 1 h. Cells were subsequently washed three times and incubated with biotinylated horse anti-mouse antibody and goat anti-rabbit secondary antibody. Excess antibody was removed by four washes, and the cells were
subsequently incubated with Vectastain Elite ABC reagent for 30 min. Finally,
cells were washed three times with TBS–Ca-Mg and developed with Nova Red
substrate (Vector Laboratories) according to the manufacturer’s direction. Cells
were visualized under a light microscope.
Flow cytometry assay. Subconfluent monolayers of 293T cells in T25 flasks
were transfected with 8 g of plasmid gKa using Superfect (Qiagen). Twentyfour hours posttransfection, cells were infected with HSV-1 wild-type, ⌬gK, and
UL20-null viruses (MOI of 0.1). Twelve hpi, cells were treated with Accutase
(Innovative Cell Technologies, Inc., San Diego, CA) to obtain a single-cell
suspension, and the numbers were adjusted to 106 cells/ml. Appropriately diluted
concentrations of green Live/Dead fixable dead cell stain (Invitrogen) were
added to 100-l cell suspensions and incubated for 10 min at 37°C. Cells were
then washed two times with Dulbecco’s PBS-bovine serum albumin wash buffer
and stained with anti-FLAG–phycoerythrin antibody (clone M2; Abcam) for 30
min on ice in the dark, followed by two washes with Dulbecco’s PBS-bovine
serum albumin wash buffer. Cells were kept on ice, and data were acquired
within 6 h of staining by use of a FACSAria flow cytometer (BD immunocytometry system). At least 200,000 events were collected by gating on live cells, and
the data were analyzed using FlowJo software (TreeStar, Inc.), version 8.7.1.
Percentages of FLAG-positive cells were calculated and compared between
different treatment groups.
Complementation of gB-mediated virus-induced cell fusion. Nearly confluent
Vero cell monolayers were transfected with plasmids expressing gKa, gKa-R,
gKa-A40V (Ala-to-Val change), or gKa-A40T (Ala-to-Thr change). Twenty-four
hpi, the cells were infected with the gK⌬31-68/gB⌬28syn virus (MOI of 0.2).
Thirty to 36 hpi, cells were fixed with ice-cold methanol and cell fusion was
visualized by immunostaining using either anti-FLAG or anti-HSV-1 antibody, as
described above.
Quantification of cell-to-cell fusion. Quantification of cell fusion was accomplished using a chemiluminescence-based system as described previously (43, 50,
52). Briefly, subconfluent Vero cells (effector cells) in six-well plates were transfected with the plasmid expressing gKa, gKa-A40V, gKa-A40T, or gKa-R (200 ng
of each) and T7 RNA polymerase (200 ng per well). Target cells in six-well plates
were transfected with a plasmid vector expressing the luciferase gene under the
control of the T7 promoter (200 ng). The total amount of DNA transfected per
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well was kept constant at 2.4 g per well by adding the pCAGGS empty vector
plasmid DNA. Lipofectamine 2000 (Invitrogen) was used for all transfections.
Six hours posttransfection, fresh medium was added, and after 5 h of incubation,
cells were detached using trypsin-EDTA. Cells were washed once and resuspended in 1 ml of complete medium. Effector and target cells were mixed in a 1:1
ratio (100 l plus 100 l) and seeded in a 24-well plate. Twelve hours postseeding, the monolayers were infected at an MOI of 0.2 with gK⌬31-68/gB⌬28syn
virus. Twenty-four hpi, cells were washed with PBS and lysed with passive lysis
buffer, and supernatants were collected. A luciferase reporter assay system (Promega, Madison, WI) was used to quantify the luciferase activity. Luciferin substrate was added to the supernatants, and luminescence was measured with a
TD-20/20 luminometer (Turner Designs).

RESULTS
Construction of recombinant HSV-1(F) viruses carrying deletions in gK and gB. Most syncytial mutations in gK are
conserved amino acid changes located in the amino terminus
of gK predicted to localize in extracellular spaces (18) (Fig. 1).
To characterize the amino-terminal domains of gK involved in
virus-induced cell fusion, a set of three recombinant viruses
carrying in-frame deletions immediately following the signal
sequence of gK were constructed using the two-step red recombination method implemented on the HSV-1(F) genome
cloned into a bacterial artificial chromosome, as described in
Materials and Methods. Specifically, the recombinant viruses
gK⌬31-47, gK⌬31-68, and gK⌬31-117 encoded gK carrying
in-frame deletions of aa 31 to 47, 31 to 68, and 31 to 117,
respectively. In addition, a new ⌬gK virus was generated by
inserting a kanamycin gene cassette within the DNA segment
encoding the gK signal sequence immediately after codon 17
(Thr).
Single-amino-acid replacements or deletions within the carboxyl terminus of gB are known to cause extensive virus-induced cell fusion (9, 10, 28, 69). We previously showed that
deletion of the carboxyl-terminal 28 aa of gB causes extensive
cell fusion, while larger deletions, which encompassed the entire predicted alpha-helical domain H17a, were lethal for virus
replication and prevented virus-induced cell fusion (4). The
recombinant virus gB⌬28syn was constructed by deleting the
carboxyl-terminal 28 aa of gB and inserting one stop codon at
the site of the deletion. This virus was similar to the previously characterized virus HSV-1(KOS) 1511gB(⌬28), with
the exception that the gB⌬28syn virus was constructed on
the HSV-1(F) genome cloned into YEbac102 by using the
two-step red recombination method to ensure that all viruses used in the present study were constructed in similar
manners and in the same genetic background. To investigate
the potential relationships between the amino-terminal domains of gK and the carboxyl terminus of gB, a double
recombinant virus was constructed by introducing the
gK⌬31-68 mutation in the gB⌬28syn genetic background
into the YEbac102 HSV-1(F) genome, as described in Materials and Methods. All mutant viruses were confirmed by
DNA sequencing prior to recovery as infectious virus in
Vero cells, as well as after virus stocks were made in Vero or
VK302 cells (see Materials and Methods).
Kinetics of viral replication and plaque morphologies of
recombinant viruses carrying mutations in gK and/or gB. Recombinant viruses gK⌬31-47 and gK⌬31-117 produced viral
plaques that were very similar to those produced by the ⌬gK
virus on Vero cells. In contrast, the recombinant virus
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FIG. 1. HSV-1 gK membrane topology. (A) The experimentally validated topology of gK is shown in conjunction with the secondary predicted
structure of gK (18). Features of the gK topology include four membrane-spanning hydrophobic domains (hpd1 to -4), a signal sequence of 30 aa,
and two N-linked glycosylation sites (CHO). The locations of different syncytial mutations published previously (17, 18) are indicated by stars.
(B) Schematic showing the in-frame truncations within the amino terminus of gK demarcated with dotted lines spanning aa 31 to 47, 31 to 68, and
31 to 117. Similar dotted markings are also included in panel A. The gene construct encoding the amino-terminal 82 aa of gK in-frame with the
3⫻ FLAG epitope is shown.

gK⌬31-68 formed plaques of intermediate size between the
⌬gK and HSV-1(F) wild-type viruses on Vero cells (Fig. 2). All
gK mutant viruses were efficiently complemented in VK302
cells, which constitutively express gK, indicating that these
mutant viruses did not contain any secondary mutations elsewhere in their genomes.

Replication kinetics of all mutant viruses were performed at
both a high MOI (MOI of 2) and a low MOI (MOI of 0.1) on
both Vero and VK302 cells. At an MOI of 0.1, the gK⌬31-47
and gK⌬31-117 viruses replicated in a manner similar to that of
the ⌬gK virus, achieving viral titers of nearly 3 logs less than
those of the HSV-1(F) parental virus (reconstituted from
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FIG. 2. Plaque morphologies and relative sizes of gK mutant and wild-type HSV-1(F) viruses. Vero cells were infected with an MOI of 0.001,
and viral plaques were fixed with methanol and stained with anti-HSV antibodies as described in Materials and Methods. (A) Representative viral
plaques of all gK mutant viruses and the HSV-1(F) wild-type virus are shown on both Vero (A to E) and VK302 (F to J) cells (constitutively
expressing gK). (B) Bar graph showing the average plaque sizes of 70 randomly chosen viral plaques for each virus; error bars indicate the standard
error (see Materials and Methods).

pYEbac102bac) within infected cells (Fig. 3A). However, the
number of infectious virions found extracellularly was reduced
by nearly 4 logs (Fig. 3B). In contrast, the gK⌬31-68 recombinant virus replicated ⬎1 log more than the ⌬gK, gK⌬31-47,
and gK⌬31-117 viruses and approximately 1 log less than the
parental HSV-1(F) virus intracellularly (Fig. 3A), while viral
titer differences for the same viruses produced extracellularly
approached 2 logs (Fig. 3B). At an MOI of 2, all gK aminoterminal deletion mutant viruses replicated in similar manners,
achieving intracellular and extracellular viral titers which were
approximately 1.5 logs higher than those for the ⌬gK virus and
approximately 1 log lower than that for the HSV-1(F) wildtype virus (Fig. 3C and D). The ratios of viral titers obtained at
24 hpi from intracellular (cells) and extracellular spaces were
calculated (Fig. 3F). These ratios revealed that all viruses
egressed to extracellular spaces more efficiently at high-MOI
than at low-MOI infections. However, the gK mutant virus
egress from infected cells was substantially less efficient than
that of the HSV-1(F) wild-type virus at low-MOI infections
(Fig. 3F). All viruses replicated in similar manners in VK302
cells at an MOI of 0.1 (Fig. 3E) or an MOI of 2 (not shown),

indicating that the gK mutant viruses were unlikely to contain
any secondary genomic mutations.
Deletion of the carboxyl-terminal 28 aa of gB caused
extensive virus-induced cell fusion, producing a distinctive
syncytial virus plaque on Vero cells (Fig. 4A). In contrast,
the gK⌬31-68/gB⌬28syn mutant virus produced nonsyncytial, substantially smaller plaques on Vero cells (Fig. 4B),
while it produced syncytial viral plaques on the complementing VK302 cells (Fig. 4D). The gB⌬28syn virus appeared to
produce more-extensive cell fusion in VK302 cells than in
Vero cells (Fig. 4C).
Transient expression and characterization of the gKa peptide, containing the amino-terminal 82 aa of gK. We investigated whether the amino terminus of gK could complement
in trans the gK⌬31-68 defects for infectious-virus production
and gB⌬28syn-mediated virus-induced cell fusion. A gene
cassette encoding the gKa peptide was constructed to include a 3⫻ FLAG epitope inserted in frame after gK aa 82
and cloned into transient expression vector p3XFLAGCMV14 (Invitrogen, Inc.). Transient expression in Vero
cells produced protein species migrating with an apparent
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FIG. 3. One-step replication kinetics of HSV-1(F) wild-type (wt) and gK mutant viruses. Vero cells were infected at either a low MOI (MOI
of 0.1) or a high MOI (MOI of 2), and the numbers of infectious viruses produced were determined on VK302 cells at different times postinfection.
At each time point, supernatants and infected cells were collected, and virus titers were determined separately. Viral titers after low-MOI infection
are shown in panels A (intracellular) and B (supernatant). High-MOI titers are shown in panels C (intracellular) and D (supernatant). Viral titers
obtained after low-MOI infections on VK302 cells are shown in panel E. Ratios of intracellular to extracellular viral titers obtained at 24 hpi are
shown in panel F. gKins17, ⌬gK recombinant virus created by inserting a kanamycin resistance cassette after aa position 17 within the gK signal
sequence.

molecular mass of approximately 12 to 22 kDa in the absence or presence of infection with the gB⌬28syn virus (Fig.
5, lanes 5 and 6, respectively). Endo H recognizes and
cleaves high-mannose precursor carbohydrate chains characteristic of glycosylation occurring in the rough endoplasmic reticulum of cells, while Golgi network-dependent glycosylation causes resistance to endo H digestion. In
contrast, the enzyme PNGase F cleaves mature N-linked
carbohydrate chains that contain terminal sugars, such as
fucose and galactose (65, 66). Treatment of transfected or
transfected and subsequently infected Vero cell extracts
with endo H or PNGase F revealed that the gKa-related
peptide species were sensitive to both endo H and PNGase

F action. Transfected cells subsequently infected with the
gB⌬28syn virus appeared to produce a small portion of
glycosylated gKa which was resistant to glycosidase action
(Fig. 5, lanes 2 and 4).
Complementation of the replication of gK mutant viruses by
the gKa peptide. To assess whether the gKa peptide complemented the replication defect of mutant viruses gK⌬31-47
and gK⌬31-68, Vero cells were transfected either with the
gK-expressing plasmid or with the control gKa-R plasmid
containing the gKa coding sequence cloned in the reverse
orientation. This gene cassette did not code for a peptide or
the FLAG epitope, since it lacked an initiation codon and
contained two internal stop codons (not shown). All trans-
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FIG. 4. Plaque morphologies of the gB⌬28syn and gK⌬31-68/gB⌬28syn viruses on Vero and VK302 cells. Viral plaques were obtained on both
Vero and VK302 cells and visualized after methanol fixing and immunostaining with anti-HSV antibodies at 48 hpi. Magnified parts of viral plaques
are shown as insets in each photograph.

fected Vero cells (in triplicate) were subsequently infected
with either the gK⌬31-47 or the gK⌬31-68 virus. Virus
stocks were prepared at 9 or 21 hpi, and virus titers were
determined on VK302 cell monolayers. Cell-free viral titers
were increased, on average, twofold by the gKa peptide
compared with gKa-R (Fig. 6A). Intracellular titers of infected cultures were increased approximately threefold for
the gK⌬31-47 virus and 50% for the gK⌬31-68 virus in the
gKa- versus the gKa-R-transfected cells (Fig. 6B). Overall

FIG. 5. Transient expression of the gKa peptide. Vero cells were
transfected with the gKa-expressing plasmid, and gKa expression was
detected by a Western immunoblot assay utilizing the anti-FLAG
antibody. Cellular extracts from transfected Vero cells (lane 5) and
transfected cells followed by infection with the gB⌬28syn virus (lane 6)
are shown. Cellular extracts were treated with either endo H (lane 1,
gKa transfection alone; lane 2, gKa transfection followed by gB⌬28syn
infection) or PNGase F (lane 3, gKa transfection alone; lane 4, gKa
transfection followed by gB⌬28syn infection). Molecular mass markers, shown as dots, are 10, 15, and 20 kDa.

viral titers at 9 hpi were approximately twofold higher for
the gKa- than for the gK-R-transfected cells. Expression of
the full gK gene produced approximately sixfold-higher levels of infectious viruses than did expression of the gKa
peptide for the gK⌬3147 virus (Fig. 6C), and virus titers
were twofold higher for the ⌬gK31-68 virus than for the gKa
peptide (not shown).
Virus-dependent cell surface expression of the gKa peptide.
The expression of the gKa peptide on cell surfaces was
examined using immunocytochemistry under both fixed
(methanol) and live-cell conditions. Vero cells were transfected with plasmids expressing either the gKa peptide or
the control plasmid gKa-R. Twenty-four hours posttransfection with either the gKa or the gKa-R plasmid, transfected
cells were infected with the gK⌬31-68/gB⌬28syn virus. Positive reactions were visualized after staining with anti-FLAG
and anti-HSV antibodies, as described in Materials and
Methods. The anti-FLAG antibody efficiently detected expression of the gKa peptide in methanol-fixed Vero cells
transfected with the gKa-expressing plasmid and subsequently infected with the gK⌬31-68/gB⌬28syn virus. FLAGpositive cells appeared to form small syncytia throughout
the Vero cell culture. As expected, the anti-FLAG antibody
did not react with Vero cells transfected with the gKa-R
plasmid and subsequently infected with the gK⌬31-68/
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FIG. 6. Complementation of viral replication of gK mutant viruses
by the gKa peptide. Vero cells were transfected with the gKa-expressing plasmid or a control plasmid containing the gKa coding sequence
cloned in reverse (see Materials and Methods), and 24 h posttransfection, cells were infected with either the gK⌬31-47 or the gK⌬31-68
virus at an MOI of 1. To better visualize the ⬃2-fold complementation
for viral replication effect, the numbers of viral plaques obtained at the
10⫺3 dilution for extracellular (A) and combined extracellular and
intracellular (B) virus stocks obtained at 21 hpi are shown. Complementation by wild-type gK for total virus (extracellular plus intracellular) at 9 hpi in comparison to complementation by gKa is shown in
panel C. Error bars indicate the standard error.

gB⌬28syn virus (Fig. 7A, panels c and d). The anti-HSV
antibody detected HSV proteins in cells transfected with
either the gKa or the gKa-R plasmid followed by infection
with the gK⌬31-68/gB⌬28syn virus. However, an increased
amount of labeling was noted for cells transfected with the
gKa peptide in comparison to that for cells transfected with
the gKa-R plasmid. Furthermore, cells expressing the gKa
peptide appeared to form large syncytia that were positive
for HSV gene products (Fig. 7A, panel a). Similar experiments were performed, with the exception that Vero cell
monolayers were labeled with anti-FLAG or anti-HSV antibody under live conditions. Previous work has shown that
under live reaction conditions, antibodies detect only cell
surface-expressed proteins (18, 23). The anti-FLAG antibody detected gKa on Vero cell surfaces but did not react
with the control Vero cell monolayer, which was transfected
with the gKa-R plasmid (Fig. 7B, panels c and d). The
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anti-HSV antibody detected HSV proteins in Vero cells
transfected with either the gKa or the gKa-R plasmid and
subsequently infected with the gK⌬31-68/gB⌬28syn virus.
However, Vero cells expressing the gKa peptide appeared to
form relatively large syncytia, which were stained with the
anti-HSV antibody (Fig. 7B, panels a and b).
To quantify the relative amounts of gKa peptide that were
expressed on cell surfaces in the presence or absence of
virus infection and to determine whether gK or UL20p was
required for gKa cell surface expression, 293T cells were
transfected with the gKa plasmid alone or with the gKa
plasmid followed by infection with wild-type HSV-1(F),
⌬gK, or ⌬UL20 virus. 293T cells were used in these experiments instead of Vero cells, because they could readily be
prepared as single-cell populations for cytometry analysis.
Single-cell suspensions were generated by using Accutase
treatment as described in Materials and Methods. Cells
were gated on live cells, and the portion of this population
of cells that stained positive for the anti-FLAG–phycoerythrin antibody was measured. Infection with any of these
three viruses increased the basal level of FLAG epitope
detected in cells transfected with the gKa plasmid by more
than threefold (relative to that with gKa alone), indicating
that viral infection substantially increased cell surface expression of the gKa peptide independently of gK or UL20p
(Fig. 7C and D).
Complementation of gB-mediated virus-induced cell fusion
by the gKa peptide, but not by gKa peptides containing syncytial mutations. A number of syncytial mutations have been
mapped to the amino terminus of gK. One of these types of
mutation is a single-amino-acid change at Ala to either Val
or Thr at aa position 40 (17, 54). To test for the ability of the
gKa peptide or gKa-derived peptides containing either the
Ala-to-Val or the Ala-to-Thr mutation to complement
gK⌬31-68/gB⌬28syn virus-induced cell fusion, Vero cells
were transfected with plasmids encoding gKa, gKa-A40V, or
gKa-A40T. Subsequently, transfected cells were infected
with the gK⌬31-68/gB⌬28syn virus, and the amount of virusinduced cell fusion was monitored using phase-contrast microscopy. Expression of the gKa, gKa-A40V, and gKa-A40T
peptides was detected efficiently using the anti-FLAG antibody in methanol-fixed Vero cells, while there was no reaction with cells transfected with the control plasmid gKa-R
(Fig. 8A, panel e). The anti-HSV antibody detected expression of viral proteins in all infected cell monolayers; however, cells expressing the gKa peptide appeared to form
relatively large syncytia, while cells expressing either the
gKa-A40V or the gKa-A40T peptide did not exhibit any
visible signs of virus-induced cell fusion (Fig. 8A, panels a to
d). Cell fusion was also evident in cells expressing the gKa
peptide stained with the anti-FLAG antibody (Fig. 8A,
panel f). To quantify the relative amount of virus-induced
cell fusion produced by transient expression of the gKa
peptide, a previously described chemiluminescence assay
was employed (43) (see Materials and Methods). Control
samples were prepared from Vero cells transfected with
either the T7-driven luciferase plasmid alone mixed with
untransfected Vero cells or two populations of Vero cells
transfected with the T7-driven luciferase and the T7 polymerase, respectively. These two cell populations emitted
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FIG. 7. Cell surface expression of the gKa peptide. Vero cells were transfected with the gKa plasmid or the control plasmid gKa-R, and
transfected cells were infected with the gK⌬31-68/gB⌬28syn virus. Cells were stained with either the anti-FLAG (␣-FLAG) or the anti-HSV-1
(␣-HSV) antibody at 30 hpi under either methanol-fixed (A) or live (B) conditions. The percentages of FLAG-positive live cells in gKa-transfected
cells infected with either wild-type HSV-1(F) or the ⌬gK or ⌬UL20 mutant are shown as contour plots (C) and as bar graphs (D). SSC, side scatter.

background chemiluminescence after infection with the
gK⌬31-68/gB⌬28syn virus. Vero cells expressing the gKa
peptide and subsequently infected with the gK⌬31-68/
gB⌬28syn virus emitted 17 times more chemiluminescence

than control cells that did not express the gKa peptide. Vero
cells expressing the gKa-A40V or the gKa-A40T mutant
peptide produced background chemiluminescence at levels
comparable to those for negative controls (Fig. 8B).
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FIG. 8. Ability of the gKa peptide to complement gK⌬31-68/gB⌬28syn-induced cell fusion. (A) Vero cells were transfected with the gKa,
gKa-R, gKa-A40V, or gKa-A40T plasmid, and cells were subsequently infected with the gK⌬31-68/gB⌬28syn virus at an MOI of 0.2. Cells were
reacted with the anti-FLAG (␣-FLAG) or the anti-HSV (␣-HSV) antibody under methanol-fixed conditions and visualized by phase-contrast
microscopy after immunostaining. (B) Vero cells were transfected and infected as detailed above, with the exception that two different populations
of cells were transfected at the same time, with each of the gK-expressing plasmids with a plasmid expressing T7 polymerase (pol) or a plasmid
expressing the luciferase gene under the T7 promoter. These equal populations of cells were mixed together prior to infection with the
gK⌬31-68/gB⌬28syn virus. The amount of relative fusion was obtained by measuring the relative level of luminescence (RLU) emitted by cellular
extracts at 24 hpi. Error bars indicate the standard error.

DISCUSSION
HSV-1-induced cell fusion is a complex process that involves
the concerted actions of multiple viral glycoproteins and membrane proteins. Generally, it is thought that glycoproteins gD,
gB, gH, and gL form a functional complex that is required for
both virus entry and virus-induced cell fusion. Specifically, it
has been hypothesized that initial binding of gD to its cognate
host receptors triggers conformational and possibly sequential
changes to gH/gL and then gB to promote membrane fusion
(11, 64). However, in viral infections gK and UL20p are absolutely required for virus-induced cell fusion, and syncytial mutations in either gK or UL20p cause extensive cell fusion. Here,
we provide evidence in support of a model in which the gK/
UL20p complex regulates infectious-virus production and gBmediated cell fusion via the amino terminus of gK.
Most of the syncytial mutations in gK are contained within
the amino-terminal segment, which has been predicted and
experimentally verified to lie extracellularly (17, 18). Generally, these mutations cause conservative amino acid changes,
which are not predicted to alter the secondary structure of the
amino terminus of gK. One of these loci is syn20, located at aa
position 40, close to the gK signal sequence and immediately

before the first N-glycosylation site (Fig. 1). syn20 mutations
are known to cause extensive virus-induced cell fusion of all
cell types, unlike gB syncytial mutations, which can cause
weaker fusion in a more limited repertoire of cells (41). The
experiments described herein have revealed that the amino
terminus of gK is involved in infectious-virus production and
virus-induced cell fusion. Specifically, mutant virus gK⌬31-68
appeared to replicate more efficiently than mutant virus
gK⌬31-47 or gK⌬31-117. This result suggests that aa 48 to 67
contain a gK domain that regulates infectious-virus production. Furthermore, the ratio of intracellular to extracellular
gK⌬31-68 virions was more than fivefold higher than that for
the HSV-1(F) virus at a low MOI, indicating a defect in virion
egress. Consequently, viral plaques produced by the gK⌬31-68
virus were on average half the size of wild-type viral plaques,
and the quantity of infectious virus produced was approximately 1 log less.
We have shown previously that the gK/UL20 complex has
genetically separable functions in virion envelopment at the
TGN and in virus-induced cell fusion at the plasma membrane,
presumably through extracellular domains of gK and UL20
that modulate other viral glycoproteins involved in virus-in-
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duced cell fusion (44, 45). It is possible that aa 48 to 67 alter
the gK structure and its interactions with UL20p, causing defects in cytoplasmic virion envelopment and egress. This potential steric hindrance may be relieved by the slightly larger
gK deletion of aa 31 to 68, allowing for improved cytoplasmic
envelopment and egress. At high-MOI infections, all gK mutant viruses appeared to egress substantially more efficiently
than at low-MOI infections. In this regard, higher expression of
several viral proteins may compensate for the egress defects of
the gK mutant viruses because of the increased stability of the
gK mutant proteins through interactions with other viral proteins. In support of this hypothesis, gK mutant viruses appear
to replicate more efficiently in Vero cells constitutively expressing UL20p, suggesting that overexpression of UL20p may partially complement gK defects (not shown).
UL20p and gK are known to be essential for virion envelopment. However, UL20p and gK domains that function in
cytoplasmic virion envelopment can be genetically segregated
from domains that function in virus-induced cell fusion (44,
45). UL20p and gK domains that function in virion envelopment are located exclusively within their intracellular domains,
which are suspected to interact with one or more tegument and
capsid proteins during the process of cytoplasmic virion envelopment. Therefore, it is possible that perturbation of the
amino terminus of gK may alter the overall structure of gK and
UL20p, causing the observed decrease in infectious-virus production and virion egress. Alternatively, mutant gK carrying
deleted portions of the gK amino terminus may affect unknown
cytoplasmic events that create a hostile environment for viral
replication. In this regard, it is noted that overexpression of gK
in certain cell lines reduces viral titers in part by blocking viral
replication and nuclear egress from gK-transformed cells (24).
One of the most interesting aspects of this work is the
finding that the gB⌬syn28 mutation, which is known to cause
extensive virus-induced cell fusion, was drastically inhibited
in the presence of the gK⌬31-68 mutation at both low and
high MOIs. Similar findings were observed for the gK⌬31-47
mutation (not shown). However, expression of the gKa peptide, composed of the amino-terminal 82 aa of gK, efficiently
complemented the gK⌬31-47 and gK⌬31-68 amino-terminal
deletion mutants of gK for infectious-virus production as
well as the gK⌬31-68/gB⌬28syn for virus-induced cell fusion. The gKa peptide was efficiently synthesized in cells
under transient-expression conditions, and it was N glycosylated, as evidenced by its sensitivity to both endo H and
PNGase enzymes. Importantly, the gKa peptide was transported to cell surfaces only after infection with the wild-type
virus or the gK or UL20-null mutant virus. This result indicates that the gKa peptide did not require gK or UL20p for
cell surface expression, suggesting the involvement of other
viral proteins. Attempts to detect the gK⌬31-68 and
gK⌬31-47 mutant gKs tagged with the V5 epitope tag at
their carboxyl termini failed to detect significant amounts of
these gKs on cell surfaces (not shown), suggesting that
transport of the gKa peptide to cell surfaces and its ability to
modulate gB fusion may be independent of the gK⌬31-68 or
gK⌬31-47 gK molecule. Apparently, the majority of the gKa
peptide contained high-mannose carbohydrates known to be
added in the rough endoplasmic reticulum. High-mannosecontaining HSV-1 precursor glycoproteins can be trans-
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ported to cell surfaces under conditions where Golgi network-dependent glycosylation is inhibited (39). Therefore, it
is possible that the gKa peptide is transported to cell surfaces by non-Golgi network- and -TGN-dependent pathways
or, alternatively, that it cannot be glycosylated efficiently
while traversing these intracellular compartments. A small
amount of gK peptide appeared to be resistant to endo H
treatment, suggesting that some gKa peptides may contain
peripheral carbohydrates added in the Golgi and TGN compartments.
Transfection of the gKa-expressing plasmid typically produced 50% of the 293T cells expressing the gKa peptide (not
shown). Viral infections of the gK-expressing cells were performed at a low MOI (0.2). Therefore, it can be calculated that
a maximum of 10% of cells would be both transfected and
infected (0.2 ⫻ 50%). The percentages of cells expressing the
gKa peptide on their cell surfaces were 4.48% after infection
with HSV-1(F) and 4.21% after infection with the ⌬gK virus.
Therefore, virus-dependent pathways appeared to efficiently
transport gKa to cell surfaces, since a high proportion of the
infected cells expressed the gKa peptide on their cell surfaces.
Transient expression of gKa peptides that carried syncytial
mutations (Ala to Val or Ala to Thr at aa 40) failed to complement gK⌬31-68/gB⌬28syn-induced cell fusion. This result
suggests that the gKa-A40V or gKa-A40T peptide was unable
to facilitate the necessary conformational changes of the amino
terminus of gB required for virus-induced cell fusion normally
exerted by the intact gK. It is worth noting that expression of
full-length gK appeared to inhibit cell fusion caused by transient expression of gB, gD, gH, and gL, whereas gK containing
the syn1 mutation did not (3), indicating that the syn1 mutation
in gK alters the functional, and possibly physical, relationships
among gK, gB, gD, and gH/gL.
Overall, these results suggest a mechanistic model by which
gK may regulate gB-mediated virus-induced cell fusion. According to this model, the amino terminus of gK is required for
gB-mediated virus-induced cell fusion, suggesting that gB cannot assume a fully functional fusogenic conformation in the
absence of the amino terminus of gK. It is possible that the gKa
peptide interacts with the remaining portion of gK (gK⌬31-68),
restoring gK functions. However, the gKa peptide was transported to cell surfaces after infection with the ⌬gK or UL20null virus. This indicates that interactions with gK⌬31-68 are
probably not necessary for trafficking to the cell surfaces,
thereby suggesting potential interactions of the gKa peptide
with other viral or cellular proteins. Previous work has demonstrated that gK syn1 mutations do not cause virus-induced
cell fusion in the absence of gB and that gB syn3 mutations do
not cause fusion in the absence of UL20p (21). Moreover,
certain mutations within the amino terminus of the UL20p
protein (located intracellularly) cause extensive virus-induced
cell fusion, while others inhibit gB-mediated cell fusion (44,
45). We favor the hypothesis that the carboxyl terminus of gB
directly or indirectly interacts with the amino terminus of
UL20p. In this model, gB syncytial mutations affect interactions between the carboxyl terminus of gB and the amino
terminus of UL20p intracellularly, causing changes in the extracellular interactions of the amino terminus of gK with gB.
Additional experiments are needed to further clarify the roles
of both gK and UL20p in infectious-virus production and virus-
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induced cell fusion and to discern the biological significance of
UL20p/gK regulation of virus-induced cell fusion.
22.
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